Similarly, combined immunotherapy and other cardiotoxic cancer therapy (such as anti-VEGF-tyrosine kinase inhibitors, platinum-based chemotherapy, or radiotherapy) seem to increase the vulnerability for developing a CE (35). Here, VEGFA is linked to cancer.